Polar Capital’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $17.2M | Buy |
5,000,000
+500,000
| +11% | +$1.72M | 0.13% | 144 |
|
|
2020
Q2 | $13.4M | Buy |
4,500,000
+1,000,000
| +29% | +$2.97M | 0.12% | 154 |
|
|
2020
Q1 | $8.3M | Buy |
3,500,000
+3,200,000
| +1,067% | +$7.58M | 0.09% | 178 |
|
|
2019
Q4 | $480K | Hold |
300,000
| – | – | ﹤0.01% | 273 |
|
|
2019
Q3 | $537K | Sell |
300,000
-44,681
| -13% | -$80K | ﹤0.01% | 266 |
|
|
2019
Q2 | $436K | Sell |
344,681
-5,319
| -2% | -$6.73K | ﹤0.01% | 272 |
|
|
2019
Q1 | $641K | Hold |
350,000
| – | – | 0.01% | 254 |
|
|
2018
Q4 | $403K | Hold |
350,000
| – | – | ﹤0.01% | 249 |
|
|
2018
Q3 | $777K | Hold |
350,000
| – | – | 0.01% | 256 |
|
|
2018
Q2 | $858 | Hold |
350,000
| – | – | 0.01% | 248 |
|
|
2018
Q1 | $4.52M | Buy |
350,000
+250,000
| +250% | +$3.23M | 0.05% | 218 |
|
|
2017
Q4 | $1.11M | Hold |
100,000
| – | – | 0.01% | 240 |
|
|
2017
Q3 | $1.25M | Buy |
+100,000
| New | +$1.25M | 0.01% | 230 |
|